Annual Gross Profit
$483.50 M
+$94.46 M+24.28%
December 1, 2024
Summary
- As of February 21, 2025, RARE annual gross profit is $483.50 million, with the most recent change of +$94.46 million (+24.28%) on December 1, 2024.
- During the last 3 years, RARE annual gross profit has risen by +$148.10 million (+44.16%).
- RARE annual gross profit is now at all-time high.
Performance
RARE Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Profit
$147.98 M
+$29.51 M+24.91%
December 1, 2024
Summary
- As of February 21, 2025, RARE quarterly gross profit is $147.98 million, with the most recent change of +$29.51 million (+24.91%) on December 1, 2024.
- Over the past year, RARE quarterly gross profit has increased by +$32.64 million (+28.30%).
- RARE quarterly gross profit is now at all-time high.
Performance
RARE Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Gross Profit
$483.50 M
+$32.64 M+7.24%
December 1, 2024
Summary
- As of February 21, 2025, RARE TTM gross profit is $483.50 million, with the most recent change of +$32.64 million (+7.24%) on December 1, 2024.
- Over the past year, RARE TTM gross profit has increased by +$94.46 million (+24.28%).
- RARE TTM gross profit is now at all-time high.
Performance
RARE TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
RARE Gross Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.3% | +28.3% | +24.3% |
| 3 y3 years | +44.2% | +85.3% | +44.2% |
| 5 y5 years | +410.5% | +385.4% | +410.5% |
RARE Gross Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +44.3% | at high | +100.4% | at high | +54.8% |
| 5 y | 5-year | at high | +410.5% | at high | +385.4% | at high | +410.5% |
| alltime | all time | at high | -100.0% | at high | -100.0% | at high | -100.0% |
Ultragenyx Pharmaceutical Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $483.50 M(+24.3%) | $147.98 M(+24.9%) | $483.50 M(+7.2%) |
| Sep 2024 | - | $118.47 M(-5.8%) | $450.86 M(+7.5%) |
| Jun 2024 | - | $125.75 M(+37.7%) | $419.45 M(+7.0%) |
| Mar 2024 | - | $91.30 M(-20.8%) | $392.10 M(+0.8%) |
| Dec 2023 | $389.04 M(+16.1%) | $115.34 M(+32.5%) | $389.04 M(+4.7%) |
| Sep 2023 | - | $87.06 M(-11.5%) | $371.73 M(+1.4%) |
| Jun 2023 | - | $98.39 M(+11.5%) | $366.74 M(+5.0%) |
| Mar 2023 | - | $88.24 M(-10.0%) | $349.41 M(+4.3%) |
| Dec 2022 | $335.01 M(-0.1%) | $98.03 M(+19.4%) | $335.01 M(+5.7%) |
| Sep 2022 | - | $82.07 M(+1.2%) | $316.86 M(+1.5%) |
| Jun 2022 | - | $81.07 M(+9.8%) | $312.26 M(-0.9%) |
| Mar 2022 | - | $73.83 M(-7.6%) | $315.03 M(-6.1%) |
| Dec 2021 | $335.40 M(+26.6%) | $79.88 M(+3.1%) | $335.40 M(-1.8%) |
| Sep 2021 | - | $77.47 M(-7.6%) | $341.58 M(-0.5%) |
| Jun 2021 | - | $83.84 M(-11.0%) | $343.23 M(+7.5%) |
| Mar 2021 | - | $94.21 M(+9.5%) | $319.30 M(+20.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $264.90 M(+179.7%) | $86.06 M(+8.8%) | $264.90 M(+26.5%) |
| Sep 2020 | - | $79.12 M(+32.1%) | $209.33 M(+36.5%) |
| Jun 2020 | - | $59.91 M(+50.5%) | $153.32 M(+31.3%) |
| Mar 2020 | - | $39.81 M(+30.6%) | $116.80 M(+23.3%) |
| Dec 2019 | $94.71 M(+88.1%) | $30.49 M(+31.9%) | $94.71 M(+18.4%) |
| Sep 2019 | - | $23.12 M(-1.1%) | $79.97 M(+17.0%) |
| Jun 2019 | - | $23.38 M(+32.0%) | $68.35 M(+18.6%) |
| Mar 2019 | - | $17.72 M(+12.5%) | $57.62 M(+14.4%) |
| Dec 2018 | $50.35 M(+1828.3%) | $15.75 M(+37.1%) | $50.35 M(+36.0%) |
| Sep 2018 | - | $11.49 M(-9.2%) | $37.01 M(+43.9%) |
| Jun 2018 | - | $12.65 M(+21.1%) | $25.72 M(+96.9%) |
| Mar 2018 | - | $10.45 M(+333.2%) | $13.06 M(+400.3%) |
| Dec 2017 | $2.61 M(+1863.2%) | $2.41 M(+1118.7%) | $2.61 M(+1218.7%) |
| Sep 2017 | - | $198.00 K(>+9900.0%) | $198.00 K(>+9900.0%) |
| Mar 2017 | - | $0.00 | $0.00 |
| Dec 2016 | $133.00 K(>+9900.0%) | - | - |
| Dec 2015 | $0.00 | - | - |
FAQ
- What is Ultragenyx Pharmaceutical annual gross profit?
- What is the all time high annual gross profit for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical annual gross profit year-on-year change?
- What is Ultragenyx Pharmaceutical quarterly gross profit?
- What is the all time high quarterly gross profit for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical quarterly gross profit year-on-year change?
- What is Ultragenyx Pharmaceutical TTM gross profit?
- What is the all time high TTM gross profit for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical TTM gross profit year-on-year change?
What is Ultragenyx Pharmaceutical annual gross profit?
The current annual gross profit of RARE is $483.50 M
What is the all time high annual gross profit for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high annual gross profit is $483.50 M
What is Ultragenyx Pharmaceutical annual gross profit year-on-year change?
Over the past year, RARE annual gross profit has changed by +$94.46 M (+24.28%)
What is Ultragenyx Pharmaceutical quarterly gross profit?
The current quarterly gross profit of RARE is $147.98 M
What is the all time high quarterly gross profit for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high quarterly gross profit is $147.98 M
What is Ultragenyx Pharmaceutical quarterly gross profit year-on-year change?
Over the past year, RARE quarterly gross profit has changed by +$32.64 M (+28.30%)
What is Ultragenyx Pharmaceutical TTM gross profit?
The current TTM gross profit of RARE is $483.50 M
What is the all time high TTM gross profit for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high TTM gross profit is $483.50 M
What is Ultragenyx Pharmaceutical TTM gross profit year-on-year change?
Over the past year, RARE TTM gross profit has changed by +$94.46 M (+24.28%)